Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial

Shuhong Wang, Yusheng Lin, Xiao Xiong, Lu Wang, Yi Guo, Yuping Chen, Shaobin Chen, Geng Wang, Peng Lin, Hongcai Chen, Sai Ching Jim Yeung, Edwin Bremer, Hao Zhang

    Research output: Contribution to journalArticlepeer-review

    93 Scopus citations

    Fingerprint

    Dive into the research topics of 'Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial'. Together they form a unique fingerprint.

    Medicine & Life Sciences